Skip to main navigation Skip to main content

Page translation not available

This page is not available in the language that has been selected and will appear in English.

Search

Contact us

07 3737 4500

PO Box 3787

South Brisbane QLD 4101

SKB264-II-06

SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors

Open for recruitment

Trial summary

The purpose of this study is to evaluate the efficacy and safety of combination of SKB264 and Pembrolizumab in patients with selected solid tumors including cervical cancer, urothelial cancer, ovarian cancer, prostate cancer.

Trial details

Short title

SKB264-II-06

Diagnosis

Advanced solid tumours

Type of treatment

Medical Oncology

Phase

II

Locations

Investigators

Principal Investigators

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.